This study provides compelling evidence that XBL exerts significant therapeutic effects in T2DM rats, improving glycemic control, enhancing insulin sensitivity, regulating lipid metabolism, and protecting pancreatic and renal tissues from diabetes-induced injury. This evidence concerns the gene INS and type 2 diabetes mellitus.